Scientists from the University of Zurich and the University of Southern California found that transplanting specialised stem cells into the brains of mice helped rebuild damaged neural connections, restore blood vessels, and improve movement and coordination after a stroke.
These promising results have raised hope that similar techniques could one day be adapted for humans.
Stroke occurs when blood flow to part of the brain is cut off, usually by a clot or bleeding, causing brain cells to die due to lack of oxygen.
In humans this often leads to long‑term disabilities, including paralysis, speech difficulties, memory problems, and loss of motor skills, because the brain typically has very limited ability to repair itself after injury.
Current treatments focus on preventing further damage, but until now there have been no proven therapies that can truly reverse existing brain loss.
In the new study, scientists used neural progenitor cells early‑stage cells derived from induced pluripotent stem cells, which are adult human cells reprogrammed to behave like embryonic stem cells.
These cells were transplanted into the brains of mice one week after a stroke, which allowed them to survive, grow, and integrate into nearby brain tissue.
Over several weeks, many of these transplanted cells matured into functioning neurons and connected with existing brain cells, helping to rebuild neural networks that had previously been lost.
What made the findings particularly exciting was that the stem cell treatment also triggered other healing responses in the brain.
The treated mice showed the growth of new blood vessels in the damaged area, reduced inflammation, and a strengthened blood‑brain barrier a protective lining that helps keep harmful substances from entering brain tissue.
Scientists tracked improvements in movement and coordination using advanced motion tracking systems, and found that the mice treated with stem cells performed significantly better than untreated animals as time went on.
While these results are compelling, the research is still in early stages, and scientists note that additional work is needed before similar therapies could be tested in humans.
Some challenges include ensuring safety, verifying long‑term effectiveness, and determining how best to deliver the cells in a clinical setting. Despite these hurdles, the study represents one of the most promising advances yet in regenerative medicine for stroke recovery.
This breakthrough shows that stem cells have real potential to rebuild damaged brain tissue after stroke, a discovery that could transform how scientists approach one of the world’s leading causes of disability.
Leave a Reply